산모 정신건강 시장 규모, 점유율, 동향 분석 보고서 : 질병 적응증별, 치료별, 지역별, 부문별 예측(2023-2030년)

Maternal Mental Health Market Growth & Trends

The global maternal mental health market size is expected to reach USD 45.72 billion by 2030, growing at a CAGR of 28.43%, according to a new report by Grand View Research, Inc. Maternal mental health issues are a global concern that affects women of various countries and cultures. It refers to the emotional well-being of women during the pregnancy and postpartum period. The market is driven by the increasing incidence of post-partum depression, increasing awareness programs, and efforts in improving practices around maternal mental healthcare among other factors.

Efforts are being undertaken to increase awareness of maternal mental health issues and improve access to treatment and support. These efforts include screening for issues during pregnancy and after childbirth, training healthcare providers to recognize and treat these conditions, and government funding & providing resources to women and their families. For instance, in May 2023, in Canada, the Associate Minister of Health and the Minister of Mental Health and Addictions announced funding for three organizations totaling over USD 857,000 for their initiatives promoting the treatment of maternal mental health conditions. The Women's College Hospital will receive USD 372,000 from Health Canada to help create national physician guidelines for perinatal mood disorders.

In addition, the Public Health Agency of Canada will provide USD 279,000 to the Canadian Mothercraft Society to encourage secure attachment of mothers with their kids and USD 206,000 to the Families Matter Society of Calgary to lead projects aimed at promoting positive mental health conditions by enhancing their access to support services for black parents who are dealing with perinatal mood disorders.

Patients who gave birth to a child during the coronavirus (COVID-19) pandemic reported experiencing more stress during labor. In addition, depression symptoms were present in 29.6% of pregnant patients evaluated during the pandemic. COVID-19 has consequently significantly impacted peripartum mental well-being outcomes. However, the lack of access to diagnosis and pharmacological or psychological treatment during the pandemic has impacted the market.

On the other hand, the workforce shortage is expected to hinder the growth of this market. For example, one-third of Americans-about 37%-live in locations with a shortage of mental health professionals. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), there will be a shortage of 31,000 full-time equivalent mental health professionals in the U.S. by 2025. This shortage is attributed to a lack of resources, comparatively poor salaries, an aging workforce, a low number of people joining the field, and a concentration of providers in wealthy urban and suburban areas.

Maternal Mental Health Market Report Highlights

• The pregnancy and postpartum general anxiety segment accounted for the largest share in 2022. Increasing awareness and recognition of perinatal mental health issues, including anxiety disorders is the major factor driving the segment growth
• The postpartum depression segment is expected to witness a lucrative CAGR through 2023-2030 owing to the favorable reimbursement scenario, increasing awareness for screening, and approval of novel therapies
• Interpersonal psychotherapy (IPT) dominated the market in 2022 as it is considered an effective therapy for treating a variety of these conditions
• The North American market encompasses the U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players in this region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. Objective - 1
  • 1.2.2. Objective - 2
  • 1.2.3. Objective - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. Gvr's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Disease Indication and Therapy Snapshot 1
• 2.3. Competitive Landscape Snapshot

Chapter 3. Maternal Mental Health Market Variables and Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Impact Analysis
    • 3.2.1.1. Rise In Government Funding To Reduce The Maternal Mortality
    • 3.2.1.2. Increasing Incidence Of Post-Partum Depression
    • 3.2.1.3. Rise In Awareness Programs And Efforts To Improve Practices Around Maternal Mental Healthcare
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Mental Health Workforce Shortage
    • 3.2.2.2. Social Stigma Surrounding Postpartum Depression
• 3.3. Impact Of The Covid-19 Pandemic
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Analysis
  • 3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. Maternal Mental Health Market: Disease Indication Estimates & Trend Analysis

• 4.1. Disease Indication Movement Analysis & Market Share, 2022 & 2030
• 4.2. Maternal Mental Health Market Estimates & Forecast, By Disease Indication (USD Million)
• 4.3. Postpartum Depression
  • 4.3.1. Global Postpartum Depression Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.4. Dysthymia
  • 4.4.1. Global Dysthymia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.5. Pregnancy And Postpartum General Anxiety
  • 4.5.1. Global Pregnancy And Postpartum General Anxiety Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.6. Pregnancy And Postpartum Ocd
  • 4.6.1. Global Pregnancy And Postpartum Ocd Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.7. Birth-Related Ptsd
  • 4.7.1. Global Birth-Related Ptsd Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Maternal Mental Health Market: Therapy Estimates & Trend Analysis

• 5.1. Therapy Movement Analysis & Market Share, 2022 & 2030
• 5.2. Maternal Mental Health Market Estimates & Forecast, By Therapy (USD Million)
• 5.3. Antidepressants
  • 5.3.1. Global Antidepressants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Selective Serotonin Reuptake Inhibitors (Ssris)
    • 5.3.2.1. Global Selective Serotonin Reuptake Inhibitors (Ssris) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Tricyclic Antidepressants (Tcas)
    • 5.3.3.1. Global Tricyclic Antidepressants (Tcas) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.4. Interpersonal Psychotherapy (Ipt)
  • 5.4.1. Global Interpersonal Psychotherapy (Ipt) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.5. Cognitive Behavioral Therapy (Cbt)
  • 5.5.1. Global Cognitive Behavioral Therapy (Cbt) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Maternal Mental Health Market: Regional Estimates And Trend Analysis

• 6.1. Maternal Mental Health Market: Regional Outlook
• 6.2. North America
  • 6.2.1. North America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. The U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Competitive Scenario
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. U.S. Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Competitive Scenario
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Canada Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Germany
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. Germany Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. UK
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. UK Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. France Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Competitive Scenario
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Italy Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Competitive Scenario
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Spain Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Competitive Scenario
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Denmark Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Competitive Scenario
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Sweden Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Competitive Scenario
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Norway Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Japan Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. China Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. India Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. South Korea
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. South Korea Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Australia Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Thailand Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Brazil Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Mexico Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Argentina
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Argentina Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. MEA
  • 6.6.1. MEA Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. South Africa Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Saudi Arabia Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. UAE Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Kuwait Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Maternal Mental Health Market: Competitive Landscape

• 7.1. Participant Categorization
  • 7.1.1. Therapy Mama
    • 7.1.1.1. Overview
    • 7.1.1.2. Product Benchmarking
    • 7.1.1.3. Strategic Initiatives
  • 7.1.2. Canopie
    • 7.1.2.1. Overview
    • 7.1.2.2. Product Benchmarking
    • 7.1.2.3. Strategic Initiatives
  • 7.1.3. Pfizer Inc
    • 7.1.3.1. Overview
    • 7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.3.3. Product Benchmarking
    • 7.1.3.4. Strategic Initiatives
  • 7.1.4. Viatris Inc.
    • 7.1.4.1. Overview
    • 7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.4.3. Product Benchmarking
    • 7.1.4.4. Strategic Initiatives
  • 7.1.5. GlaxoSmithKline Inc.
    • 7.1.5.1. Overview
    • 7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.5.3. Product Benchmarking
    • 7.1.5.4. Strategic Initiatives
  • 7.1.6. Alembic Pharmaceuticals Limited
    • 7.1.6.1. Overview
    • 7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.6.3. Product Benchmarking
    • 7.1.6.4. Strategic Initiatives
  • 7.1.7. Mallinckrodt Inc.
    • 7.1.7.1. Overview
    • 7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.7.3. Product Benchmarking
    • 7.1.7.4. Strategic Initiatives
  • 7.1.8. Sage Therapeutics, Inc.
    • 7.1.8.1. Overview
    • 7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.8.3. Product Benchmarking
    • 7.1.8.4. Strategic Initiatives
  • 7.1.9. Bausch Health Companies Inc.
    • 7.1.9.1. Overview
    • 7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.9.3. Product Benchmarking
    • 7.1.9.4. Strategic Initiatives
  • 7.1.10. Magellan Health, Inc.
    • 7.1.10.1. Overview
    • 7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.1.10.3. Product Benchmarking
    • 7.1.10.4. Strategic Initiatives
• 7.2. Participant's Overview
• 7.3. Financial Performance
• 7.4. Product Benchmarking
• 7.5. Company Market Share Analysis, 2022
• 7.6. Strategy Mapping
  • 7.6.1. Expansion
  • 7.6.2. Acquisition
  • 7.6.3. Product/Service Launch
  • 7.6.4. Others

Chapter 8. Analyst View